Atlas Trials

Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury

Clinical trial NCT01143064 · COMPLETED

Trial details

NCT number
NCT01143064
Sponsor
BHR Pharma, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Brain Injuries
Start date
2010-06-01
Primary completion
2014-03-01
Enrollment
1195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.